Mint Tower Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Mint Tower Capital Management’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,500	Closed	-$1.25M	–	199
2025 Q1	$1.25M	Buy	+9,500	New	+$1.18M	0.44%	51

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mint Tower Capital Management's ITCI Position: Q2 2025 in Review

Mint Tower Capital Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 9,500 shares — an estimated $1.25M sold.

Mint Tower Capital Management first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $1.25M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Mint Tower Capital Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Mint Tower Capital Management sold 9,500 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $1.25M.
Mint Tower Capital Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Mint Tower Capital Management's Intra-Cellular Therapies Inc. position peaked at $1.25M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Mint Tower Capital Management's 13F filing for Q2 2025, filed 11 Aug 2025.